Drug Trial Radar · NCT04376554
Effect of Tebipenem on Normal Human Intestinal Microbiota
Last checked: Nov 19, 2026Latest source record: May 4, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Feb 10, 2020
Primary completion
Apr 6, 2021
Study completion Apr 6, 2021
Sponsor
- Lead sponsor
- Spero TherapeuticsIndustry
- Sponsor type
- Industry
- Collaborators
- IQVIA Pty Ltd
- First posted
- May 6, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The overall purpose of this study is to support the development of an oral formulation of TBPM-PI-HBr by assessing the potential ecological effects of tebipenem on the normal intestinal microbiota as compared to the effects of oral amoxicillin-clavulanate.
Conditions
- Healthy Volunteers
Interventions
TBPM-PI-HBrDrug
TBPM-PI-HBr (2 x 300mg tablets) PO q8h \[±1 hour\] for 10 days
amoxicillin-clavulanateDrug
amoxicillin-clavulanate (1 × 500mg/125mg tablet) PO q8h \[±1 hour\] for 10 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes in the number of microorganisms in the intestinal flora of healthy subjects during and after 10 days of oral administration of TBPM-PI-HBr or amoxicillin-clavulanateTime frame: Change from baseline (Day-1), at Days 2, 4, 7, 10, 14, 21, 90, and 180
- Changes in the types of microorganisms in the intestinal flora of healthy subjects during and after 10 days of oral administration of TBPM-PI-HBr or amoxicillin-clavulanateTime frame: Change from baseline (Day-1), at Days 2, 4, 7, 10, 14, 21, 90, and 180
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Karolinska University Hospital
Huddinge, Stockholm County, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.